Term Description

Full sequencing analysis of the three coding exons and intron/exon boundaries of the VHL gene as well as gross deletion/duplication analysis to determine gene copy number for coding exons 1-3 is performed.[OMIM: 608537][NCBI Gene ID: 7428] This test is performed for patients with suspected of having von Hippel-Lindau (VHL) disease, an autosomal dominant cancer predisposition syndrome characterized by retinal angiomas, hemangioblastomas, pheochromocytomas (PCCs), renal cell carcinomas, pancreatic cysts, and neuroendocrine tumors. PMID: 8493574 For genetic testing for suspected VHL-related erythrocytosis, or familial erythrocytosis, type 2 (ECYT2) disease, see VHL gene full mutation analysis LOINC 82528-1.

Part Description

LP31890-4   VHL gene
The VHL gene (von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase) [HGNC Gene ID:12687] is located on chromosome 3p25.3. Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008] [NCBI Gene ID:7428] Source: National Center for Biotechnology Information (NCBI) Gene

LOINC Names Get Info

Fully-Specified Name
VHL gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen
Long Common Name
VHL gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
Short Name
VHL gene Del+Dup + Full Mut Anl Bld/T
Display Name
VHL gene del+dup and full mutation analysis Molgen Doc (Bld/Tiss)
Consumer Name Alpha Get Info
VHL gene variant analysis, Blood or tissue specimen

Part Model Get Info

  • Component
    VHL gene deletion+duplication & full mutation analysis
    LP229918-0
    • Analyte
      VHL gene deletion+duplication & full mutation analysis
      LP229918-0
      • Component Numerator
        VHL gene deletion+duplication & full mutation analysis
        LP229918-0
        • Component Numerator Core
          VHL gene
          LP31890-4
        • Component Numerator Core Suffix
          deletion+duplication & full mutation analysis
          LP200206-3
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    Find
    LP6813-2
  • Time
    Pt
    LP6960-1
  • System
    Bld/Tiss
    LP7061-7
    • System Core
      Bld/Tiss
      LP7061-7
    • Super System
      NULL
       
  • Scale
    Doc
    LP32888-7
  • Method
    Molgen
    LP6404-0

Associated Observations

81247-9 Master HL7 genetic variant reporting panel

LOINCNameR/O/CCardinalityExample UCUM Units
81247-9Master HL7 genetic variant reporting panel
Indent81306-3Variables that apply to the overall study
IndentIndent53577-3Reason for studyO0..*
IndentIndent51967-8Genetic disease assessed [ID]O0..*
IndentIndent51963-7Medication assessed [ID]C0..*
IndentIndent48018-6Gene studied [ID]C0..*
IndentIndent36908-2Gene mutations tested for in Blood or Tissue by Molecular genetics method NominalC0..*
IndentIndent51959-5Range(s) of DNA sequence examinedC0..*
IndentIndent81293-3Description of ranges of DNA sequences examinedC0..1
IndentIndent51968-6Discrete variation analysis overall interpretationR1..1
IndentIndent83006-7Deletion-duplication overall interpretationC
IndentIndent51969-4Genetic analysis reportO0..1
IndentIndent81291-7Variant ISCNC
IndentIndent62374-4Human reference sequence assembly versionC0..1
IndentIndent81303-0HGVS version [ID]O0..1
IndentIndent82115-7dbSNP version [ID]O0..1
IndentIndent83007-5COSMIC version [ID]O
IndentIndent83008-3ClinVar version [ID]O
Indent81250-3Discrete genetic variant panel0..n
IndentIndent83005-9Variant category
IndentIndent81252-9Discrete genetic variantC0..1
IndentIndent48018-6Gene studied [ID]C0..1
IndentIndent51958-7Transcript reference sequence [ID]C0..1
IndentIndent48004-6DNA change (c.HGVS)C0..1
IndentIndent48005-3Amino acid change (pHGVS)C0..1
IndentIndent48019-4DNA change typeO0..1
IndentIndent48006-1Amino acid change [Type]O0..1
IndentIndent48013-7Genomic reference sequence [ID]C0..1
IndentIndent81290-9Genomic DNA change (gHGVS)C
IndentIndent69547-8Genomic ref allele [ID]C0..1
IndentIndent81254-5Genomic allele start-endC0..1
IndentIndent69551-0Genomic alt allele [ID]C0..1
IndentIndent84414-2Haplotype nameO
IndentIndent81255-2dbSNP [ID]O0..1
IndentIndent81257-8CIGAR [ID]O0..1
IndentIndent48001-2Cytogenetic (chromosome) locationO0..1
IndentIndent48002-0Genomic source class [Type]O0..1
IndentIndent81304-8Variant analysis method [Type]O
IndentIndent53037-8Genetic variation clinical significance [Imp]O0..1
IndentIndent69548-6Genetic variant assessmentO
IndentIndent81259-4Associated phenotypeO0..1
IndentIndent53034-5Allelic stateC0..1
IndentIndent81258-6Sample variant allelic frequency [NFr]O0..1%
IndentIndent82121-5Allelic read depthO0..1{#}
IndentIndent82120-7Allelic phaseO0..1
IndentIndent82309-6Basis for allelic phase [Type]O
Indent81297-4Structural variant panel
IndentIndent82155-3Genomic structural variant copy number{#}
IndentIndent81299-0Structural variant reported arrCGH [Ratio]C0..1{Ratio}
IndentIndent81300-6Structural variant [Length]O0..1{#}
IndentIndent81301-4Structural variant outer start and endO0..1{Range}
IndentIndent81302-2Structural variant inner start and endO0..1{Range}
Indent81251-1Complex genetic variant panel0..n
IndentIndent81260-2Complex genetic variant [ID]C0..1
IndentIndent81262-8Complex variant HGVS nameC0..1
IndentIndent81263-6Complex variant typeC0..1
IndentIndent81259-4Associated phenotypeO0..1
IndentIndent53037-8Genetic variation clinical significance [Imp]O0..1
IndentIndent53034-5Allelic stateO0..1
IndentIndent82309-6Basis for allelic phase [Type]O
IndentIndent81250-3Discrete genetic variant panel0..n
IndentIndentIndent83005-9Variant category
IndentIndentIndent81252-9Discrete genetic variantC0..1
IndentIndentIndent48018-6Gene studied [ID]C0..1
IndentIndentIndent51958-7Transcript reference sequence [ID]C0..1
IndentIndentIndent48004-6DNA change (c.HGVS)C0..1
IndentIndentIndent48005-3Amino acid change (pHGVS)C0..1
IndentIndentIndent48019-4DNA change typeO0..1
IndentIndentIndent48006-1Amino acid change [Type]O0..1
IndentIndentIndent48013-7Genomic reference sequence [ID]C0..1
IndentIndentIndent81290-9Genomic DNA change (gHGVS)C
IndentIndentIndent69547-8Genomic ref allele [ID]C0..1
IndentIndentIndent81254-5Genomic allele start-endC0..1
IndentIndentIndent69551-0Genomic alt allele [ID]C0..1
IndentIndentIndent84414-2Haplotype nameO
IndentIndentIndent81255-2dbSNP [ID]O0..1
IndentIndentIndent81257-8CIGAR [ID]O0..1
IndentIndentIndent48001-2Cytogenetic (chromosome) locationO0..1
IndentIndentIndent48002-0Genomic source class [Type]O0..1
IndentIndentIndent81304-8Variant analysis method [Type]O
IndentIndentIndent53037-8Genetic variation clinical significance [Imp]O0..1
IndentIndentIndent69548-6Genetic variant assessmentO
IndentIndentIndent81259-4Associated phenotypeO0..1
IndentIndentIndent53034-5Allelic stateC0..1
IndentIndentIndent81258-6Sample variant allelic frequency [NFr]O0..1%
IndentIndentIndent82121-5Allelic read depthO0..1{#}
IndentIndentIndent82120-7Allelic phaseO0..1
IndentIndentIndent82309-6Basis for allelic phase [Type]O
Indent82118-1Pharmacogenomics result panel
IndentIndent48018-6Gene studied [ID]1..*
IndentIndent84413-4Genotype display name
IndentIndent53040-2Genetic variation's effect on drug metabolismC0..1
IndentIndent51961-1Genetic variation's effect on drug efficacyC0..1
IndentIndent83009-1Genetic variation's effect on high-risk allele
IndentIndent82117-3Medication usage implications panelO0..*
IndentIndentIndent51963-7Medication assessed [ID]R1..*
IndentIndentIndent82116-5Medication usage suggestion [Type]C1..1
IndentIndentIndent83010-9Medication usage suggestion [Narrative]C
Indent83011-7Haplotype definition panel
IndentIndent48018-6Gene studied [ID]C0..1
IndentIndent84414-2Haplotype nameO
IndentIndent81250-3Discrete genetic variant panel0..n
IndentIndentIndent83005-9Variant category
IndentIndentIndent81252-9Discrete genetic variantC0..1
IndentIndentIndent48018-6Gene studied [ID]C0..1
IndentIndentIndent51958-7Transcript reference sequence [ID]C0..1
IndentIndentIndent48004-6DNA change (c.HGVS)C0..1
IndentIndentIndent48005-3Amino acid change (pHGVS)C0..1
IndentIndentIndent48019-4DNA change typeO0..1
IndentIndentIndent48006-1Amino acid change [Type]O0..1
IndentIndentIndent48013-7Genomic reference sequence [ID]C0..1
IndentIndentIndent81290-9Genomic DNA change (gHGVS)C
IndentIndentIndent69547-8Genomic ref allele [ID]C0..1
IndentIndentIndent81254-5Genomic allele start-endC0..1
IndentIndentIndent69551-0Genomic alt allele [ID]C0..1
IndentIndentIndent84414-2Haplotype nameO
IndentIndentIndent81255-2dbSNP [ID]O0..1
IndentIndentIndent81257-8CIGAR [ID]O0..1
IndentIndentIndent48001-2Cytogenetic (chromosome) locationO0..1
IndentIndentIndent48002-0Genomic source class [Type]O0..1
IndentIndentIndent81304-8Variant analysis method [Type]O
IndentIndentIndent53037-8Genetic variation clinical significance [Imp]O0..1
IndentIndentIndent69548-6Genetic variant assessmentO
IndentIndentIndent81259-4Associated phenotypeO0..1
IndentIndentIndent53034-5Allelic stateC0..1
IndentIndentIndent81258-6Sample variant allelic frequency [NFr]O0..1%
IndentIndentIndent82121-5Allelic read depthO0..1{#}
IndentIndentIndent82120-7Allelic phaseO0..1
IndentIndentIndent82309-6Basis for allelic phase [Type]O

Basic Attributes

Class
MOLPATH.MUT
Type
Laboratory
First Released
Version 2.58
Last Updated
Version 2.65 (MIN)
Order vs. Observation
Both

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Gen VHL delece+duplikace a kompletní mutační analýza:Nález:Časový bod:Krev/tkáň:Dokument:Molekulární genetika
el-GRGreek (Greece)Γονίδιο VHL ανάλυση διαγραφής+διπλασιασμού & πλήρους μετάλλαξης:Εύρεση:Pt:Αίμα/Ιστός:Doc:Μοριακή γενετική
Synonyms: Doc MOLPATH MOLPATH.MUT Pt Αίμα Αίμα/Ιστός ανάλυση διαγραφής+διπλασιασμού & πλήρους μετάλλαξης Γονίδιο Γονίδιο VHL διαγραφή διαγραφή+διπλασιασμός διπλασιασμός Εύρεση Ιστός Μοριακή γενετική πλήρης ανάλυση μεταλλάξεων
es-ESSpanish (Spain)Gen VHL estudio delecion+duplicacion y estudio mutacional completo:Hallazgo:Punto temporal:Sangre o tejido:Doc:Genética molecular
es-MXSpanish (Mexico)Eliminación del gen VHL + duplicación y análisis de mutación completo:Hallazgo:Punto temporal:Sangre o tejido:Documento:Genética molecular
fr-FRFrench (France)VHL gène délétion+duplication et analyse complète des mutations:Recherche:Ponctuel:Sang/Tissu:Document:Biologie moléculaire
it-ITItalian (Italy)VHL, gene Delezione+duplicazione & analisi di mutazione completa:Osservazione:Pt:Sangue/Tess:Doc:Molgen
Synonyms: delezione e duplicazione Gene VHL Genetica molecolare Mutazione genica Osservazione Patologia molecolare Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & Strisci
nl-NLDutch (Netherlands)VHL-gen deletie + duplicatie & volledige mutatie analyse:bevinding:moment:bloed of weefsel:document:moleculair genetisch onderzoek
Synonyms: molgen VHL gen
pl-PLPolish (Poland)VHL gen delecja+duplikacja i pełna analiza mutacji:stwierdzenie:punkt w czasie:krew lub tkanka:dokument:genetyka molekularna
Synonyms: diagnostyka molekularna Gen VHL
tr-TRTurkish (Turkey)VHL geni delesyon+duplikasyon ve tam mutasyon analizi:Bulgu:Zmlı:Kan/Dk:Dokm:Molgen
Synonyms: çiftleme
zh-CNChinese (China)VHL 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法
Synonyms: VHL 综合征;von Hippel-Lindau 综合征;林岛综合征;视网膜和中枢神经血管母细胞瘤病 临床文档型;临床文档;文档;文书;医疗文书;临床医疗文书 全血或组织;血液/组织;血液或组织 分子病理学.基因突变;分子病理学.突变;分子病理学试验.基因突变;分子病理学试验.突变;分子病理学试验类.突变;基因突变;突变 分子病理学;分子病理学试验 分子遗传学;分子遗传学方法;分子遗传学类方法;分子遗传学类检验方法;包括 RFL、PCR 及其他方法在内,用于在分子基础上检测遗传属性的方法的大类;聚合酶链反应;聚合酶链式反应 发现是一个原子型临床观察指标,并不是作为印象的概括陈述。体格检查、病史、系统检查及其他此类观察指标的属性均为发现。它们的标尺对于编码型发现可能是名义型,而对于叙述型文本之中所报告的发现,则可能是叙述型。;发现物;所见;结果;结论 基因复制;基因重复;重复 基因缺失(基因缺失、缺损、基因缺损、基因删除、删除、基因丢失)+重复(基因重复);基因缺失+重复 完整突变分析;综合突变分析 时刻;随机;随意;瞬间 未作说明的组织;组织;组织 & 涂片 染色体缺失;染色体区带缺失;基因缺失;缺损;基因缺损;基因删除;删除;基因丢失 缺失(基因缺失、缺损、基因缺损、基因删除、删除、基因丢失)+重复(基因重复、重复基因、重复型基因、复制型基因)与全面的突变分析(突变全面分析、完整的突变分析、彻底的突变分析、全面型突变分析、全面式突变分析、突变全分析、突变彻底分析、全面突变分析) 血;血液 遗传基因;遗传因子;吉恩;生物基因

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=82533-1